| # | Drug | Count |
|---|---|---|
| 0 | MELPHALAN HYDROCHLORIDE | 67 |
| 1 | TOPOTECAN | 23 |
| 2 | RANIBIZUMAB | 19 |
| 3 | CARBOPLATIN | 16 |
| 4 | BEVACIZUMAB | 15 |
| 5 | VERTEPORFIN FOR INJECTION | 14 |
| 6 | PREDNISOLONE | 12 |
| 7 | PREDNISOLONE ORAL | 12 |
| 8 | PREDNISOLONE ORAL SOLUTION | 12 |
| 9 | PREDNISONE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VORETIGENE NEPARVOVEC-RZYL | 8 | 0.0526 |
| 1 | VERTEPORFIN FOR INJECTION | 14 | 0.0095 |
| 2 | FOSAMPRENAVIR CALCIUM | 1 | 0.0076 |
| 3 | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND DEXAMETHASONE | 5 | 0.0046 |
| 4 | TOPOTECAN | 23 | 0.0038 |
| 5 | PROPARACAINE HYDROCHLORIDE | 2 | 0.0037 |
| 6 | FLUORESCEIN | 2 | 0.0032 |
| 7 | MELPHALAN HYDROCHLORIDE | 67 | 0.0026 |
| 8 | CHLOROQUINE PHOSPHATE | 1 | 0.0015 |
| 9 | TOPOTECAN HYDROCHLORIDE | 3 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 37 |
| 1 | Topoisomerase Inhibitor [EPC] | 23 |
| 2 | Corticosteroid [EPC] | 22 |
| 3 | Platinum-based Drug [EPC] | 16 |
| 4 | Photoenhancer [EPC] | 14 |
| 5 | Anticholinergic [EPC] | 8 |
| 6 | Cholinergic Muscarinic Antagonist [EPC] | 6 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 6 |
| 8 | Insulin Analog [EPC] | 6 |
| 9 | Prostaglandin Analog [EPC] | 6 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Photoenhancer [EPC] | 14 | 0.0036 |
| 1 | Diagnostic Dye [EPC] | 2 | 0.0031 |
| 2 | Anticholinergic [EPC] | 8 | 0.0005 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 4 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 5 | Topoisomerase Inhibitor [EPC] | 23 | 0.0003 |
| 6 | Antiseptic [EPC] | 1 | 0.0002 |
| 7 | alpha-1 Adrenergic Agonist [EPC] | 1 | 0.0002 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 37 | 0.0002 |
| 9 | Sulfone [EPC] | 2 | 0.0002 |